Cargando…

Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects

PURPOSE: The primary aim of this study was to evaluate the performance of the study product, in terms of volumizing activity as well as the duration of the effect, in women with age-related midfacial volume defects. In addition, the study allowed the evaluation of the tolerability of the product by...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparavigna, Adele, La Gatta, Annalisa, Bellia, Gilberto, La Penna, Laura, Giori, Andrea Maria, Vecchi, Gabriele, Tenconi, Beatrice, Schiraldi, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502383/
https://www.ncbi.nlm.nih.gov/pubmed/32982362
http://dx.doi.org/10.2147/CCID.S262839
_version_ 1783584214331949056
author Sparavigna, Adele
La Gatta, Annalisa
Bellia, Gilberto
La Penna, Laura
Giori, Andrea Maria
Vecchi, Gabriele
Tenconi, Beatrice
Schiraldi, Chiara
author_facet Sparavigna, Adele
La Gatta, Annalisa
Bellia, Gilberto
La Penna, Laura
Giori, Andrea Maria
Vecchi, Gabriele
Tenconi, Beatrice
Schiraldi, Chiara
author_sort Sparavigna, Adele
collection PubMed
description PURPOSE: The primary aim of this study was to evaluate the performance of the study product, in terms of volumizing activity as well as the duration of the effect, in women with age-related midfacial volume defects. In addition, the study allowed the evaluation of the tolerability of the product by both volunteers and investigators. PATIENTS AND METHODS: Twenty-two female volunteers, aged 42–60 years, participated in this study, which was performed under dermatological control in a single center. After an initial visit at baseline to verify adherence to the protocol criteria, volunteers received an injection of Aliaxin(®) SV (IBSA Farmaceutici Italia Srl), followed 3–4 weeks later by a second touch-up treatment to treat eventual asymmetries. Four subsequent visits, the last performed 9 months from the first injection, were performed to evaluate clinically and instrumentally the efficacy of the treatment. RESULTS: Clinical and statistically significant improvement in cheek volume was recorded after the first postinjection visit, and the effect was maintained until the end of the study period. A clinically measurable amelioration of wrinkle severity was also observed. By 3D picture recording and subsequent quantitative analysis, it was possible to determine the efficacy in terms of increased facial volume, which was already appreciable at the first visit, was further increased at the second and third visits and was maintained at the fourth and last visits. The injections were very well tolerated by the volunteers, as determined by their self-evaluation questionnaires. CONCLUSION: The results of the study confirm the esthetic performance of the study product on age-related midfacial volume defects. The very strong high-volumizing activity of the study product was not only properly determined by the investigators but also confirmed by self-evaluation by the volunteers. These effects were obtained with no appreciable undesired effects.
format Online
Article
Text
id pubmed-7502383
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75023832020-09-24 Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects Sparavigna, Adele La Gatta, Annalisa Bellia, Gilberto La Penna, Laura Giori, Andrea Maria Vecchi, Gabriele Tenconi, Beatrice Schiraldi, Chiara Clin Cosmet Investig Dermatol Original Research PURPOSE: The primary aim of this study was to evaluate the performance of the study product, in terms of volumizing activity as well as the duration of the effect, in women with age-related midfacial volume defects. In addition, the study allowed the evaluation of the tolerability of the product by both volunteers and investigators. PATIENTS AND METHODS: Twenty-two female volunteers, aged 42–60 years, participated in this study, which was performed under dermatological control in a single center. After an initial visit at baseline to verify adherence to the protocol criteria, volunteers received an injection of Aliaxin(®) SV (IBSA Farmaceutici Italia Srl), followed 3–4 weeks later by a second touch-up treatment to treat eventual asymmetries. Four subsequent visits, the last performed 9 months from the first injection, were performed to evaluate clinically and instrumentally the efficacy of the treatment. RESULTS: Clinical and statistically significant improvement in cheek volume was recorded after the first postinjection visit, and the effect was maintained until the end of the study period. A clinically measurable amelioration of wrinkle severity was also observed. By 3D picture recording and subsequent quantitative analysis, it was possible to determine the efficacy in terms of increased facial volume, which was already appreciable at the first visit, was further increased at the second and third visits and was maintained at the fourth and last visits. The injections were very well tolerated by the volunteers, as determined by their self-evaluation questionnaires. CONCLUSION: The results of the study confirm the esthetic performance of the study product on age-related midfacial volume defects. The very strong high-volumizing activity of the study product was not only properly determined by the investigators but also confirmed by self-evaluation by the volunteers. These effects were obtained with no appreciable undesired effects. Dove 2020-09-16 /pmc/articles/PMC7502383/ /pubmed/32982362 http://dx.doi.org/10.2147/CCID.S262839 Text en © 2020 Sparavigna et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sparavigna, Adele
La Gatta, Annalisa
Bellia, Gilberto
La Penna, Laura
Giori, Andrea Maria
Vecchi, Gabriele
Tenconi, Beatrice
Schiraldi, Chiara
Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title_full Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title_fullStr Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title_full_unstemmed Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title_short Evaluation of the Volumizing Performance of a New Volumizer Filler in Volunteers with Age-Related Midfacial Volume Defects
title_sort evaluation of the volumizing performance of a new volumizer filler in volunteers with age-related midfacial volume defects
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502383/
https://www.ncbi.nlm.nih.gov/pubmed/32982362
http://dx.doi.org/10.2147/CCID.S262839
work_keys_str_mv AT sparavignaadele evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT lagattaannalisa evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT belliagilberto evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT lapennalaura evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT gioriandreamaria evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT vecchigabriele evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT tenconibeatrice evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects
AT schiraldichiara evaluationofthevolumizingperformanceofanewvolumizerfillerinvolunteerswithagerelatedmidfacialvolumedefects